1. Home
  2. VVOS

as of 12-02-2025 4:00pm EST

$2.05
$0.08
-3.76%
Stocks Health Care Medical Specialities Nasdaq

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Chart Type:
Time Range:
Founded: 2016 Country:
United States
United States
Employees: N/A City: LITTLETON
Market Cap: 19.4M IPO Year: 2020
Target Price: $6.75 AVG Volume (30 days): 116.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.91 EPS Growth: N/A
52 Week Low/High: $1.98 - $7.95 Next Earning Date: 11-19-2025
Revenue: $17,317,000 Revenue Growth: 18.76%
Revenue Growth (this year): 19.45% Revenue Growth (next year): 70.80%

AI-Powered VVOS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 69.33%
69.33%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Vivos Therapeutics Inc. News

VVOS Breaking Stock News: Dive into VVOS Ticker-Specific Updates for Smart Investing

All VVOS News

Share on Social Networks: